Delivery systems and methods for PFO closure device with two anchors

Information

  • Patent Grant
  • 8568447
  • Patent Number
    8,568,447
  • Date Filed
    Monday, October 15, 2012
    12 years ago
  • Date Issued
    Tuesday, October 29, 2013
    11 years ago
Abstract
A device closes septal openings, such as a patent foramen ovale (PFO). The device includes two anchors and a flexible connector. Tension applied to one or more strings attached to the device causes the device to collapse into a reduced profile form for withdrawal into a delivery catheter, thereby facilitating retrieval of the device after insertion into a septal opening.
Description
BACKGROUND OF THE INVENTION

The invention relates to devices and methods that are used to close septal openings, such as a patent foramen ovale (PFO). A PFO is a persistent, one-way, usually flap-like opening in the wall between the right atrium (RA) and left atrium (LA) of the heart. Because left atrial pressure is normally higher than right atrial pressure, the flap usually stays closed. Under certain conditions, however, right atrial pressure can exceed left atrial pressure, which creates the possibility that blood could pass from the right atrium to the left atrium and allow blood clots to enter the systemic circulation. It is desirable to avoid this situation.


SUMMARY OF THE INVENTION

Embodiments of the present invention are directed to devices for closing septal defects such as PFOs, and for delivering and recovering closure devices. The closure devices in these embodiments generally include a proximal anchor, a distal anchor, and a flexible anchor connector for connecting the two anchors. The connector is preferably a flexible elastomeric layer, which can also be used to promote tissue ingrowth or for drug delivery. The flexible material can also be covered with a biocompatible glue to promote adherence to tissue or growth factors to accelerate tissue ingrowth.


In accordance with some embodiments of the invention, options are provided for multiple delivery/recovery of the same device without withdrawing the device from the delivery sheath or otherwise replacing it. Other embodiments include the use of a single use delivery/recovery string that reduces the complexity of the delivery/recovery system and the procedure itself.


These and other features will become apparent from the following detailed description and drawings. The inventions are capable of other and different embodiments and its several details may be capable of modifications in various respects, all without departing from the invention. Accordingly, the drawings and description are to be regarded as illustrative in nature and not in a restrictive or limiting sense.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a perspective view of a closure device according to a first embodiment.



FIGS. 2-7 are partial side and partial cross-sectional views showing the delivery and recovery of a closure device of the type shown in FIG. 1.



FIGS. 8-11 are partial side and partial cross-sectional views of the removal of a closure device according to a second embodiment of the present invention.



FIG. 12 is a perspective view of a device according to a third embodiment of the present invention.



FIGS. 13-17 are partial side and partial cross-sectional views of a device and steps for delivering and removing the device of FIG. 12.



FIG. 18 is a perspective view of a device according to a fourth embodiment of the present invention.



FIGS. 19-22 are partial side and partial cross-sectional views of a device and steps for delivering and recovering the device of FIG. 18.



FIG. 23 is a perspective view of a device according to a fifth embodiment of the present invention.



FIGS. 24-28 are partial side and partial cross-sectional views of the device of FIG. 23 and steps for recovering it.



FIGS. 29-34 are a perspective view of a sixth embodiment and partial side and cross-sectional views of the device of FIG. 29 and its delivery and recovery.



FIGS. 35-37 are perspective views of further embodiments of devices according to the present invention.





DETAILED DESCRIPTION OF THE INVENTION

This invention relates to structures of the type shown in application Ser, No. 10/326,535, filed Dec. 19, 2002, published application no. 2003/0191495, which is expressly incorporated herein by reference. This invention includes further embodiments of the device, and methods to allow a physician or other practitioner to deliver and deploy the device in a defect, then recover and remove it if desired from a defect after deployment. Some embodiments allow for multiple deployments and removals of the same occluder. Other embodiments have a single delivery/recovery mechanism requiring a simpler delivery/recovery system. While described for use with a patent foramen ovale (PFO), these systems and methods could be used for occluding or holding together other defects.


As shown in FIG. 1, a closure device 10 has a distal anchor 12 for placement on the left atrial side of a PFO, a proximal anchor 14 for placement in the right atrial side of a PFO, a proximal attachment point 16 spaced from anchor 14 for attachment and release from a wire through a catheter on an anchor connector 22 for connecting anchors 12 and 14, and frangible attachment points 18, 20 on anchor 14. A bore 24 is provided along the lengthwise direction in proximal anchor 14. A string 26 extends from attachment point 18 on anchor 14 attachment point 16 to attachment point 20 on anchor 14. The string then runs through bore 24 to the end of anchor 14, and across to a permanent attachment point 28 on anchor 12. Within bore 24, the string can move relative to anchor 14.


In this embodiment and others, the distal anchor, the proximal anchor, and the connectors between the anchor members can each be made of a bioresorbable material.


These components can be fabricated from a single piece of a bioresorbable polymer or by a laminated composite of two or more materials to provide a mix of properties; for example, anchors can have stiff centers and flexible edges, and blood contacting surfaces can have controlled porosity or surface texture to promote fast and thorough endothelialization, while minimizing thrombosis. In addition, the tissue contacting surface of the anchors can be designed to provide added stability, such as being roughened. Other components, such as connection balls and strings, can also be made of bioresorbable materials; e.g., the string can be made of bioresorbable fibers that are braided or otherwise combined for strength.


The anchors are elongated supports, preferably generally cylindrical with rod-like bodies with ends that are atraumatic, and preferably rounded. In size, the distal anchor component could be about 15-30 mm long and 2 mm in diameter with a circular cross-section. The proximal anchor can have similar dimensions and shape, although it can be shorter in overall length. Other distal and proximal anchor structures are also possible. For example, sides of the anchors can be flattened, especially the side which will contact the atrial septum. The generally cylindrical shape for the anchors means that they have at least some portions with generally round cross-sections, but could have one or more flattened sides, cut-outs, or other variations from an “ideal” cylinder.


The anchor connector can be elastomeric and resilient and made from a material, such as polyester, biological tissue, bioresorbable polymer, small diameter springs (e.g., Nitinol), or spongy polymeric material, and can include thrombogenic or inflammatory materials. Alternatively, the anchor connector can be made of multiple strands of material such as polymer fibers. The anchor connector can be textured or porous. These kinds of surfaces can also produce inflammatory responses, and therefore can promote faster tissue ingrowth and faster defect closure.



FIGS. 2-4 show the delivery of device 10 to a PFO. Device 10 is shown inside a delivery sheath 30, and represented as delivered in phantom with anchors 12′ and 14′ and anchor connector 22′. While in the delivery sheath, the string between the anchors has some slack in it. The delivery sheath is introduced so that anchor 12 is positioned in the left atrium 32. This positioning is typically done by providing delivery sheath 30 in or at the edge of left atrium 32 through PFO tunnel 34, and retracting sheath 30 so that anchor 12 is deployed in left atrium 32 against septum primum 38 and septum secundum 39. Sheath 30 is retracted until anchor 14 is deployed in right atrium 36 as indicated in FIG. 2 in phantom. FIGS. 3 and 4 show a side view and a top view of device 10 in PFO tunnel 34. A catheter 40 is maintained in contact with attachment point 16.



FIGS. 5-7 show how device 10 can be retrieved as described, such as if the practitioner determines that it is not sitting properly. As shown in FIG. 5, delivery sheath 30 is placed up close to anchor 14 while catheter 40 connected to attachment point 16 is pulled. As also shown in FIG. 6, the portion 42 of string 26 connected to attachment point 18 breaks, leaving a loose strand of string. The string also pulls attachment point 20 from anchor 14, but continues to extend through bore 24 of anchor 14 and be rigidly attached to anchor 12. Continued pulling on catheter 40 continues to pull string 26 and causes anchor 12 to rotate as shown to move from a position where it is generally perpendicular to the lengthwise direction of delivery sheath 30 to a sufficient angle where it can be drawn within sheath 30. This pulling action also reduces the length of string between anchors 14 and 12 until they are close to each other or in actual contact. This causes anchor 12 to rotate as shown in a direction opposite to that of anchor 14. Anchor 12 and anchor connector 22 are pulled through the PFO tunnel and back into sheath 30.


In this embodiment, because some of the attachment points have been broken, the device can be retrieved once, but would typically not be redeployed in this form. This embodiment does provide the ability to deliver and retrieve the device using one string and one wire.



FIGS. 8-11 illustrate another embodiment with a device 80 including distal anchor 82 and proximal anchor 84. A string 86 extends from a rigid attachment point 88 on anchor 84 located at about a midpoint along the lengthwise direction of anchor 84, and extends through a loop (or hook) 90 in a delivery catheter 92 within a sheath 94 from this loop, the string extends to an end of anchor 84, through a lengthwise bore 96 and across a PFO tunnel to a rigid attachment point 98 at anchor 82. Loop 90 is movable from a locked position in which the string is held rigidly, to an unlocked position in which the string can move freely. Control for the loop is provided to the operator, e.g., by pulling one end of the loop until the looping wire is fully withdrawn. In this embodiment, with the loop in the locked position, the delivery process is substantially the same as that shown in the embodiment in connection with FIGS. 2-4.


To retrieve device 80, loop 90 is unlocked from its locked delivery position, and delivery catheter 92 is withdrawn. This motion pulls on string 86 and hence anchor 84. Because the distance to attachment point 88 is shorter than the distance to the end of anchor 84, this pulling causes the string lengths to equalize and anchor 84 to rotate. The length of string between anchors 84 and 82 is reduced until anchor 82 rotates in a direction opposite to that of anchor 84 so that the anchors are end to end and can be withdrawn into sheath 94.


This embodiment is useful for recovering the device and can be redelivered. Only one connection to the device is needed.



FIGS. 12-17 show yet another embodiment with a device 120. Referring particularly to FIGS. 12 and. 13, distal anchor 122 is similar to that in the prior embodiments and has a rigid attachment point 126 at one end. Proximal anchor 124 for the right atrium is also elongated and generally cylindrical, but it has a cut out to form a flat axial face 128 over a portion of the length at one end, and a flat radial face 130. The cutout provides a smaller profile than without the cutout.


A passage 132 extends along a diameter of anchor 124 with a first ball 134 and a second ball 136 at either end of passage 132 and connected with a string. Ball 136 is slightly larger in diameter than passage 132, but is small enough that ball 134 can be pulled through passage 132 when sufficient force is exerted on it. The ball may deform in the process. An attachment ball 138 is coupled to ball 136 to provide an attachment point for the operator.


These balls can provide distinct functions, such as ball 138 serving as a coupling, and ball 134 serving as a stop. While the contact points and stops are described in this embodiment and in other embodiments as balls and while they are preferably spherical in some embodiments, they can have any shape suitable to form a coupling to a wire in conjunction with a holder that can push or pull them, or a stop, or some other connector. These couplings can be formed differently within one device when there are several couplings; for example, a spherical ball that can be gripped with a grappling hook could be used in one case for a coupling, and a hemispheric piece could be used as a stop.


Referring to FIGS. 14-17, the device is shown in a deployed position (FIG. 14) from which it can be retrieved. A wire 140 in a delivery sheath 142 is connected to ball 138 for attachment. As shown in FIG. 15, the pulling force represented by arrow 144 pulls ball 134 through passage 132. After ball 134 is clear of passage 132, sheath 142 is drawn back. Further pulling force causes anchor 124 to rotate and anchor 122 to rotate in a direction opposite to that of anchor 124. As shown in FIG. 17, device 120 can be pulled back fully into sheath 142.



FIG. 18 shows another embodiment of a device 180 with anchors 182 and 184, and with a single ball 186 serving as a connector and a stop on the inner side of a radial passage 188. A string 190 extends to one end of anchor 184, through a lengthwise passage 192, across to anchor 182 (through a PFO tunnel when deployed), through a lengthwise passage 194 in anchor 182, and to a rigid connection with ball 186. Two string ends extend away from the device and are used to control the device, but with ball 186, the string forms an unbroken loop with two ends.



FIG. 19 shows device 180 loaded in a sheath 198 and ready for delivery. A delivery catheter 200 within sheath. 198 provides an inward force to one end of the anchor. The delivery sheath would typically be positioned in the left atrium and retracted to allow anchor 182 to be released within the left atrium. Then, sheath 198 would be withdrawn into the right atrium and further pulled back to release anchor 184 within the right atrium. The resulting deployed device 180 is shown in FIG. 20. After a successful deployment, the strings can be cut.


Referring to FIGS. 20-22, to recover device 180, a force is applied to lower end 202 of string 190 in order to rotate anchor 184, causing anchor 182 to rotate in a direction opposite to that of anchor 184 and be returned into sheath 198.


In this embodiment, the device can be redeployed if desired. From FIG. 22, by pulling on upper string 204, ball 186 is moved back against anchor 184 at passage 188 as shown by 186′. At that point. FIG. 22 is substantially similar to FIG. 19, which shows device 180 ready to be deployed.


Referring to FIG. 23, a device 230 has a right atrial anchor 234 with a portion cut out of a generally cylindrical side by making a radial cut part way into the anchor and an axial cut along part of the lengthwise direction, with the cuts at right angles to form a cutout section. The resulting faces are similar to those in the device of FIG. 12. In this case, a first ball 236 is connected with a string 238 to the flat axial face that is formed by the radial cut, while a second ball 240 is attached with a string 242 that extends through a lengthwise bore 244 in anchor 234. That string further extends to anchor 232 where there is a rigid attachment at one end. At the other end of left atrial anchor 232 is an enlarged diameter portion 246.


Referring to FIG. 24, when device 230 is loaded in a delivery sheath 250 for delivery, increased diameter portion 246 of anchor 232 is larger than the opening of a delivery catheter 252 and is at the innermost distal end of catheter 252. The string portion 254 between the anchors is shown with some slack, and upper and lower wires 256,258 are connected to respective attachment balls 236,240.


The device is delivered in a similar manner to those described above to a deployed position as shown in FIG. 25. The wires may provide enough stiffness to keep device 230 in place as catheter 252 is removed, or an additional mandrel or catheter (not shown) can be positioned against device 230 to prevent the device from moving toward the proximal end as the sheath is withdrawn toward the proximal end.



FIGS. 26-28 show the retrieval process for device 230. In this case, lower wire 258 is pulled to cause anchor 234 to rotate. In FIG. 27, the upper wire is pulled to reintroduce slack 254 (FIG. 28). The upper wire is released to allow the device to assume the configuration of FIG. 24. Note that in this position, it can be redeployed into the PFO.



FIG. 29 shows another device 290 which has similarities with the embodiment of FIG. 23, with one ball 296 attached to a face 298 formed by the partial radial cut, but with another ball 300 attached to an end of anchor 294. In this embodiment, unlike a number of others, there is no lengthwise bore through either anchor. Anchors 292 and 294 are attached with permanent attachment points with a string 304 at the same end of each anchor, and therefore there is slack that would not be taken up by the operator.


Referring to FIG. 30, device 290 is shown in a sheath 306 and ready for delivery. As indicated above, wires 308 and 310 against respective balls 296 and 300 may be able to provide sufficient resistance to keep the device from being withdrawn as sheath 306 is withdrawn around device 290. If not, an additional device can be inserted to hold device 290 in place as sheath 306 is withdrawn. Device 290 is thus employed in a manner similar to that described above, with the sheath provided in the left atrium, or withdrawn to allow anchor 292 to be positioned, and then further withdrawn into the right atrium to allow anchor 294 to be positioned.



FIGS. 31-34 show the device being retracted into a delivery sheath by pulling on the lowermost wire that is connected to the ball attached at the end of the right atrial anchor. In this embodiment, both anchors rotate in opposite directions until they are end-to-end and drawn into the delivery sheath. From the position in FIG. 34, the device could be redeployed.



FIG. 35 shows another embodiment of a device 350, similar to that shown in FIG. 29, except that the string connecting the anchors extends from one end of one anchor to an opposite end of the other anchor, thereby extending across the anchor connector. This string connection helps to pull anchor 352 so that it rotates in a direct opposite to the rotation of anchor 354.


Referring to FIG. 36, in another embodiment, a device 360 has distal anchor 362 and proximal anchor 364 connected together by strings 365 and 366, both of which pass through a loop 367. Anchor 364 also has balls 368 and 369 serving as connection points. In this case, retrieving the device includes providing a connection to ball 369 and pulling to rotate anchor 364, with continued pulling causing rotation of anchor 362. This device would thus be deployed and retrieved in a manner similar to those described above, and could be redeployed multiple times.


Referring to FIG. 37, a device 370 has a distal anchor 372 and a proximal anchor 374. It also has attachment balls that are similar to those shown in FIG. 36, namely one at one end and one in the middle of the anchor. Distal anchor 372 has strings 375 and 376 extending from each end. String 375 extends from one end of anchor 372, through a loop.



377 that is connected to anchor 374, through a loop 378 connected with a string 376 to another end of anchor 372 and then to the opposite end of anchor 374. String 375 can also have small strings attached to it, referred to here as whiskers 380. These could be provided by being glued to the string, or if the string is in a braided form, the string can be intentionally frayed. The whiskers can help provide some inflammatory effect between tissues, such as between the tissue flaps of a PFO to encourage tissue ingrowth. The device can be delivered and redeployed in a manner similar to that described above.


The closure devices described here can optionally be used along with suturing or stapling techniques deployed from the catheter or sheath.


The devices can use radiopaque fillers or marker bands fabricated from noble metals such as platinum or gold to allow x-ray visualization. These markers can be attached using a variety of common methods, such as adhesive bonding, lamination between two layers of polymer, or vapor deposition where the anchors of the devices can be sewn or stapled to septum primum or secundum for better dislodgment resistance. Also, in some embodiments, an anchor connector can, if desired, be covered with biocompatible glue to adhere to the tissue or can be loaded or coated with drugs or growth factors to promote healing. The glue and also certain drugs can be stored in any cavities in the anchors and released after deployment.


The anchor connector can be mounted to allow the proximal anchor to slide relative to the connector. A biasing spring (not shown), which may be an expandable coil spring, can be formed at an outer end of the central connector to bias the proximal anchor toward the distal anchor when both are.


The various closure devices described herein can include a number of advantageous features. The closure devices preferably have an atraumatic shape to reduce trauma during deployment or removal. In addition, the devices can be self-orienting for ease of deployment. Furthermore, because of the flexible anchor connector, the devices generally conform to the anatomy instead of the anatomy conforming to the devices, which is especially useful in long tunnel defects. The devices also generally have a relatively small profile within the heart after deployment. The flexible anchor connector of the devices can encourage faster tissue ingrowth, and thus faster defect closure. Furthermore, there are generally no exposed thrombogenic components on the left and right atrial sides. The devices can also advantageously include bioresorbable components, which can disappear over time.


Other benefits of the devices can include possible use of a relatively small diameter delivery sheath, use of reduced or no metal mass in the device, ease of manufacturing, cost effectiveness, and overall design simplicity.


Having described embodiments, it should be apparent that modifications can be made without departing from the scope of the invention. For example, while the anchors are shown generally as straight and elongated, they could be curved.

Claims
  • 1. A septal occluder comprising: a proximal anchor member for deployment proximate a first side of a septal defect, the proximal anchor having a substantially cylindrical shape, a radial passage extending along a diameter of the proximal anchor, and an axial passage extending along a longitudinal axis of the proximal member;a distal anchor member for deployment proximate a second side of the septal defect;a flexible connector connecting the proximal and distal anchor members; anda removal string for retrieving the device from its intended delivery location, wherein the removal string is connected through the radial passage to a ball stop and connected via the axial passage to the distal member.
  • 2. The occluder of claim 1, wherein the distal anchor member has a substantially cylindrical shape and a longitudinal axis.
  • 3. The occluder of claim 2, wherein a tension applied to the removal string causes the ball stop to pass through the radial passage, thereby permitting the string tension to be transmitted through the axial passage to the distal member, thereby reducing a distance between the proximal and distal anchor members and aligning the longitudinal axes of the proximal and distal anchor members.
  • 4. The occluder of claim 1, wherein a tension applied to the removal string causes the ball stop to pass through the radial passage, thereby causing the occluder to collapse into a form suitable for withdrawal into a delivery sheath.
  • 5. The occluder of claim 1, wherein the distal anchor member has a substantially cylindrical shape and has an axial passage.
  • 6. The occluder of claim 5, wherein each end of the removal string is used for controlling the device.
  • 7. The occluder of claim 5, wherein the removal string is slidingly mounted in the proximal anchor and in the distal anchor.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation application of U.S. application Ser. No. 11/110,975 filed Apr. 20, 2005, now U.S. Pat. No. 8,308,760; which claims the benefit under 35 USC §119(e) to U.S. Application Ser. No. 60/568,527 filed May 6, 2004, now expired. The disclosure of each of the prior applications is considered part of and is incorporated by reference in the disclosure of this application.

US Referenced Citations (324)
Number Name Date Kind
3294631 Mancusi Dec 1966 A
3824631 Burstein et al. Jul 1974 A
3874238 King et al. Apr 1975 A
3875648 Bone Apr 1975 A
3924631 Mancusi, Jr. Dec 1975 A
4006747 Kronenthal et al. Feb 1977 A
4007743 Blake Feb 1977 A
4149327 Hammer et al. Apr 1979 A
4425908 Simon Jan 1984 A
4610674 Suzuki et al. Sep 1986 A
4626245 Weinstein Dec 1986 A
4693249 Schenck et al. Sep 1987 A
4696300 Anderson Sep 1987 A
4710181 Fuqua Dec 1987 A
4710192 Liotta et al. Dec 1987 A
4738666 Fuqua Apr 1988 A
4836204 Landymore et al. Jun 1989 A
4840623 Quackenbush Jun 1989 A
4902508 Badylak et al. Feb 1990 A
4915107 Rebuffat et al. Apr 1990 A
4917089 Sideris Apr 1990 A
4921479 Grayzel May 1990 A
4956178 Badylak et al. Sep 1990 A
5021059 Kensey et al. Jun 1991 A
5037433 Wilk et al. Aug 1991 A
5041129 Hayhurst et al. Aug 1991 A
5049131 Deuss Sep 1991 A
5078736 Behl Jan 1992 A
5106913 Yamaguchi et al. Apr 1992 A
5108420 Marks Apr 1992 A
5149327 Oshiyama et al. Sep 1992 A
5163131 Row et al. Nov 1992 A
5167363 Adkinson et al. Dec 1992 A
5167637 Okada et al. Dec 1992 A
5171259 Inoue Dec 1992 A
5176659 Mancini Jan 1993 A
5192301 Kamiya et al. Mar 1993 A
5222974 Kensey et al. Jun 1993 A
5226879 Ensminger et al. Jul 1993 A
5236440 Hlavacek Aug 1993 A
5245023 Peoples et al. Sep 1993 A
5245080 Aubard et al. Sep 1993 A
5250430 Peoples et al. Oct 1993 A
5257637 El Gazayerli Nov 1993 A
5275826 Badylak et al. Jan 1994 A
5282827 Kensey et al. Feb 1994 A
5284488 Sideris Feb 1994 A
5304184 Hathaway et al. Apr 1994 A
5312341 Turi May 1994 A
5312435 Nash et al. May 1994 A
5316262 Koebler May 1994 A
5320611 Bonutti et al. Jun 1994 A
5334217 Das Aug 1994 A
5350363 Goode et al. Sep 1994 A
5354308 Simon et al. Oct 1994 A
5364356 Hofling Nov 1994 A
5411481 Allen et al. May 1995 A
5411520 Nash et al. May 1995 A
5413584 Schulze et al. May 1995 A
5417699 Klein et al. May 1995 A
5425744 Fagan et al. Jun 1995 A
5433727 Sideris Jul 1995 A
5451235 Lock et al. Sep 1995 A
5453099 Lee et al. Sep 1995 A
5478353 Yoon Dec 1995 A
5480353 Garza, Jr. Jan 1996 A
5480424 Cox Jan 1996 A
5486193 Bourne et al. Jan 1996 A
5507811 Koike et al. Apr 1996 A
5534432 Peoples et al. Jul 1996 A
5540712 Kleshinski et al. Jul 1996 A
5562632 Davila et al. Oct 1996 A
5577299 Thompson et al. Nov 1996 A
5601571 Moss Feb 1997 A
5603703 Elsberry et al. Feb 1997 A
5618311 Gryskiewicz Apr 1997 A
5620461 Muijs Van De Moer et al. Apr 1997 A
5626599 Bourne et al. May 1997 A
5634936 Linden et al. Jun 1997 A
5649950 Bourne et al. Jul 1997 A
5649959 Hannam et al. Jul 1997 A
5662681 Nash et al. Sep 1997 A
5663063 Peoples et al. Sep 1997 A
5683411 Kavteladze et al. Nov 1997 A
5690674 Diaz Nov 1997 A
5693085 Buirge et al. Dec 1997 A
5702421 Schneidt et al. Dec 1997 A
5709707 Lock et al. Jan 1998 A
5713864 Verkaart Feb 1998 A
5717259 Schexnayder Feb 1998 A
5720754 Middleman et al. Feb 1998 A
5725552 Kotula et al. Mar 1998 A
5733294 Forber et al. Mar 1998 A
5733337 Carr, Jr. et al. Mar 1998 A
5741297 Simon Apr 1998 A
5772641 Wilson Jun 1998 A
5776162 Kleshinski Jul 1998 A
5776183 Kanesaka et al. Jul 1998 A
5797960 Stevens et al. Aug 1998 A
5800516 Fine et al. Sep 1998 A
5810884 Kim Sep 1998 A
5820594 Fontirroche et al. Oct 1998 A
5823956 Roth et al. Oct 1998 A
5829447 Stevens et al. Nov 1998 A
5853420 Chevillon et al. Dec 1998 A
5853422 Huebsch et al. Dec 1998 A
5855614 Stevens et al. Jan 1999 A
5861003 Latson et al. Jan 1999 A
5865791 Whayne et al. Feb 1999 A
5879366 Shaw et al. Mar 1999 A
5893856 Jacob et al. Apr 1999 A
5902287 Martin May 1999 A
5902319 Daley May 1999 A
5904703 Gilson May 1999 A
5919200 Stambaugh et al. Jul 1999 A
5924424 Stevens et al. Jul 1999 A
5928250 Koike et al. Jul 1999 A
5944691 Querns et al. Aug 1999 A
5944738 Amplatz et al. Aug 1999 A
5955110 Patel et al. Sep 1999 A
5976174 Ruiz Nov 1999 A
5980505 Wilson Nov 1999 A
5989268 Pugsley, Jr. et al. Nov 1999 A
5993475 Lin et al. Nov 1999 A
5993844 Abraham et al. Nov 1999 A
5997575 Whitson et al. Dec 1999 A
6010447 Kardjian Jan 2000 A
6010517 Baccaro Jan 2000 A
6019753 Pagan Feb 2000 A
6024756 Huebsch et al. Feb 2000 A
6027519 Stanford Feb 2000 A
6030007 Bassily et al. Feb 2000 A
6056760 Koike et al. May 2000 A
6071998 Muller et al. Jun 2000 A
6077291 Das Jun 2000 A
6077880 Castillo et al. Jun 2000 A
6079414 Roth Jun 2000 A
6080182 Shaw et al. Jun 2000 A
6096347 Geddes et al. Aug 2000 A
6106913 Scardino et al. Aug 2000 A
6113609 Adams Sep 2000 A
6117159 Huebsch et al. Sep 2000 A
6126686 Badylak et al. Oct 2000 A
6132438 Fleischman et al. Oct 2000 A
6143037 Goldstein et al. Nov 2000 A
6152144 Lesh et al. Nov 2000 A
6152935 Kammerer et al. Nov 2000 A
6165183 Kuehn et al. Dec 2000 A
6165204 Levinson et al. Dec 2000 A
6168588 Wilson Jan 2001 B1
6171329 Shaw et al. Jan 2001 B1
6174322 Schneidt Jan 2001 B1
6174330 Stinson Jan 2001 B1
6183443 Kratoska et al. Feb 2001 B1
6187039 Hiles et al. Feb 2001 B1
6190353 Makower et al. Feb 2001 B1
6190357 Ferrari et al. Feb 2001 B1
6197016 Fourkas et al. Mar 2001 B1
6199262 Martin Mar 2001 B1
6206895 Levinson Mar 2001 B1
6206907 Marino et al. Mar 2001 B1
6214029 Thill et al. Apr 2001 B1
6217590 Levinson Apr 2001 B1
6221092 Koike et al. Apr 2001 B1
6227139 Nguyen et al. May 2001 B1
6228097 Levinson et al. May 2001 B1
6231561 Frazier et al. May 2001 B1
6245080 Levinson Jun 2001 B1
6245537 Williams et al. Jun 2001 B1
6261309 Urbanski Jul 2001 B1
6265333 Dzenis et al. Jul 2001 B1
6270515 Linden et al. Aug 2001 B1
6277138 Levinson et al. Aug 2001 B1
6277139 Levinson et al. Aug 2001 B1
6287317 Makower et al. Sep 2001 B1
6290674 Roue et al. Sep 2001 B1
6299635 Frantzen Oct 2001 B1
6306150 Levinson Oct 2001 B1
6306424 Vyakarnam et al. Oct 2001 B1
6312443 Stone Nov 2001 B1
6312446 Huebsch et al. Nov 2001 B1
6315791 Gingras et al. Nov 2001 B1
6316262 Huisman et al. Nov 2001 B1
6319263 Levinson Nov 2001 B1
6322548 Payne et al. Nov 2001 B1
6328727 Frazier et al. Dec 2001 B1
6334872 Termin et al. Jan 2002 B1
6342064 Koike et al. Jan 2002 B1
6344048 Chin et al. Feb 2002 B1
6344049 Levinson et al. Feb 2002 B1
6346074 Roth Feb 2002 B1
6348041 Klint et al. Feb 2002 B1
6352552 Levinson et al. Mar 2002 B1
6355052 Neuss et al. Mar 2002 B1
6356782 Sirimanne et al. Mar 2002 B1
6358238 Sherry Mar 2002 B1
6364853 French et al. Apr 2002 B1
6371904 Sirimanne et al. Apr 2002 B1
6375625 French et al. Apr 2002 B1
6375671 Kobayashi et al. Apr 2002 B1
6379342 Levinson Apr 2002 B1
6379368 Corcoran et al. Apr 2002 B1
6387104 Pugsley, Jr. et al. May 2002 B1
6398796 Levinson Jun 2002 B2
6402772 Amplatz et al. Jun 2002 B1
6419669 Frazier et al. Jul 2002 B1
6426145 Moroni Jul 2002 B1
6436088 Frazier et al. Aug 2002 B2
6440152 Gainor et al. Aug 2002 B1
6450987 Kramer Sep 2002 B1
6460749 Levinson et al. Oct 2002 B1
6482224 Michler et al. Nov 2002 B1
6488706 Solymar Dec 2002 B1
6494846 Margolis Dec 2002 B1
6494888 Laufer et al. Dec 2002 B1
6508828 Akerfeldt et al. Jan 2003 B1
6514515 Williams Feb 2003 B1
6548569 Williams et al. Apr 2003 B1
6551303 Van Tassel et al. Apr 2003 B1
6551344 Thill Apr 2003 B2
6585719 Wang Jul 2003 B2
6585755 Jackson et al. Jul 2003 B2
6596013 Yang et al. Jul 2003 B2
6599448 Ehrhard, Jr. et al. Jul 2003 B1
6610764 Martin et al. Aug 2003 B1
6616675 Evard et al. Sep 2003 B1
6623508 Shaw et al. Sep 2003 B2
6623518 Thompson et al. Sep 2003 B2
6626936 Stinson Sep 2003 B2
6629901 Huang Oct 2003 B2
6666861 Grabek Dec 2003 B1
6669722 Chen et al. Dec 2003 B2
6689589 Huisman et al. Feb 2004 B2
6712804 Roue et al. Mar 2004 B2
6712836 Berg et al. Mar 2004 B1
6726696 Houser et al. Apr 2004 B1
6828357 Martin et al. Dec 2004 B1
6838493 Williams et al. Jan 2005 B2
6867247 Williams et al. Mar 2005 B2
6867248 Martin et al. Mar 2005 B1
6867249 Lee et al. Mar 2005 B2
6921410 Porter Jul 2005 B2
7494496 Swain et al. Feb 2009 B2
20010010481 Blanc et al. Aug 2001 A1
20010014800 Frazier et al. Aug 2001 A1
20010025132 Alferness et al. Sep 2001 A1
20010034537 Shaw et al. Oct 2001 A1
20010037129 Thill Nov 2001 A1
20010039435 Roue et al. Nov 2001 A1
20010039436 Frazier et al. Nov 2001 A1
20010041914 Frazier et al. Nov 2001 A1
20010041915 Roue et al. Nov 2001 A1
20010044639 Levinson Nov 2001 A1
20010049492 Frazier et al. Dec 2001 A1
20020010481 Jayaraman Jan 2002 A1
20020019648 Akerfeldt et al. Feb 2002 A1
20020022859 Hogendijk Feb 2002 A1
20020022860 Borillo et al. Feb 2002 A1
20020026208 Roe et al. Feb 2002 A1
20020029048 Miller Mar 2002 A1
20020032459 Horzewski et al. Mar 2002 A1
20020032462 Houser et al. Mar 2002 A1
20020034259 Tada Mar 2002 A1
20020035374 Borillo et al. Mar 2002 A1
20020043307 Ishida et al. Apr 2002 A1
20020049457 Kaplan et al. Apr 2002 A1
20020052572 Franco et al. May 2002 A1
20020058989 Chen et al. May 2002 A1
20020077555 Schwartz Jun 2002 A1
20020095174 Tsugita et al. Jul 2002 A1
20020096183 Stevens et al. Jul 2002 A1
20020099389 Michler et al. Jul 2002 A1
20020099390 Kaplan et al. Jul 2002 A1
20020103492 Kaplan et al. Aug 2002 A1
20020107531 Schreck et al. Aug 2002 A1
20020111537 Taylor et al. Aug 2002 A1
20020111637 Kaplan et al. Aug 2002 A1
20020111647 Khairkhahan et al. Aug 2002 A1
20020120323 Thompson et al. Aug 2002 A1
20020128680 Pavlovic Sep 2002 A1
20020129819 Feldman et al. Sep 2002 A1
20020164729 Skraly et al. Nov 2002 A1
20020169377 Khairkhahan et al. Nov 2002 A1
20020169478 Schwartz et al. Nov 2002 A1
20020183786 Girton Dec 2002 A1
20020183787 Wahr et al. Dec 2002 A1
20020183823 Pappu Dec 2002 A1
20020198563 Gainor et al. Dec 2002 A1
20030004533 Dieck et al. Jan 2003 A1
20030023266 Borillo et al. Jan 2003 A1
20030028213 Thill et al. Feb 2003 A1
20030032979 Mortier et al. Feb 2003 A1
20030045893 Ginn Mar 2003 A1
20030050665 Ginn Mar 2003 A1
20030055455 Yang et al. Mar 2003 A1
20030057156 Peterson et al. Mar 2003 A1
20030059640 Marton et al. Mar 2003 A1
20030065379 Babbs et al. Apr 2003 A1
20030100920 Akin et al. May 2003 A1
20030120337 Van Tassel et al. Jun 2003 A1
20030139819 Beer et al. Jul 2003 A1
20030171774 Freudenthal et al. Sep 2003 A1
20030191495 Ryan et al. Oct 2003 A1
20030195530 Thill Oct 2003 A1
20030204203 Khairkhahan et al. Oct 2003 A1
20040044361 Frazier et al. Mar 2004 A1
20040073242 Chanduszko Apr 2004 A1
20040098121 Opolski May 2004 A1
20040116949 Ewers et al. Jun 2004 A1
20040133236 Chanduszko Jul 2004 A1
20040176799 Chanduszko et al. Sep 2004 A1
20040210301 Obermiller Oct 2004 A1
20040234567 Dawson Nov 2004 A1
20050025809 Hasirci et al. Feb 2005 A1
20050043759 Chanduszko Feb 2005 A1
20050113868 Devellian May 2005 A1
20050267523 Devellian et al. Dec 2005 A1
20050273135 Chanduszko et al. Dec 2005 A1
20050288786 Chanduszko Dec 2005 A1
20060122647 Callaghan et al. Jun 2006 A1
20060265004 Callaghan et al. Nov 2006 A1
20060271089 Alejandro et al. Nov 2006 A1
20070010851 Chanduszko et al. Jan 2007 A1
20070167981 Opolski Jul 2007 A1
Foreign Referenced Citations (56)
Number Date Country
9413645 Oct 1994 DE
0362113 Apr 1990 EP
0474887 Mar 1992 EP
0839549 May 1998 EP
0861632 Sep 1998 EP
1013227 Jun 2000 EP
1046375 Oct 2000 EP
1222897 Jul 2002 EP
WO 9625179 Aug 1996 WO
WO 9631157 Oct 1996 WO
WO 9807375 Feb 1998 WO
WO 9808462 Mar 1998 WO
WO 9816174 Apr 1998 WO
WO 9829026 Jul 1998 WO
WO 9851812 Nov 1998 WO
WO 9905977 Feb 1999 WO
WO 9918861 Apr 1999 WO
WO 9918862 Apr 1999 WO
WO 9918864 Apr 1999 WO
WO 9918870 Apr 1999 WO
WO 9918871 Apr 1999 WO
WO 9930640 Jun 1999 WO
WO 9966846 Dec 1999 WO
WO 0027292 May 2000 WO
WO 0044428 Aug 2000 WO
WO 01008600 Feb 2001 WO
WO 0119256 Mar 2001 WO
WO 0121247 Mar 2001 WO
WO 0128432 Apr 2001 WO
WO 0130268 May 2001 WO
WO 0149185 Jul 2001 WO
WO 0178596 Oct 2001 WO
WO 0193783 Dec 2001 WO
WO 0217809 Mar 2002 WO
WO 0224106 Mar 2002 WO
WO 03024337 Mar 2003 WO
WO 03053493 Jul 2003 WO
WO 03059152 Jul 2003 WO
WO 03063732 Aug 2003 WO
WO 03077733 Sep 2003 WO
WO 03082076 Oct 2003 WO
WO 03103476 Dec 2003 WO
WO 2004032993 Apr 2004 WO
WO 2004037333 May 2004 WO
WO 2004043266 May 2004 WO
WO 2004043508 May 2004 WO
WO 2004052213 Jun 2004 WO
WO 2005006990 Jan 2005 WO
WO 2005018728 Mar 2005 WO
WO 2005027752 Mar 2005 WO
WO 2005074813 Aug 2005 WO
WO 2005092203 Oct 2005 WO
WO 2005110240 Nov 2005 WO
WO 2005112779 Dec 2005 WO
WO 2006036837 Apr 2006 WO
WO 2006102213 Sep 2006 WO
Non-Patent Literature Citations (48)
Entry
Anthanasiou, T., “Coronary Artery Bypass with the Use of a Magnetic Distal Anastomotic Device: Surgical Technique and Preliminary Experience”, The Heart Surgery Forum #2004-1024, 2004, 4 pgs.
Bachthaler et al., “Corrosion of Tungsten Coils After Peripheral Vascular Embolization Theraphy: Influence on Outcome and Tungsten Load”, Catherization and Cardiovascular Interventions, vol. 62, pp. 380-384, 2004.
European Examination Report, European Application No. 03729663.9, mailed Jul. 16, 2008 (5 pages).
European Examination Report, European Application No. 03731562.9, mailed Jul. 18, 2008 (3 pages).
European Examination Report, European Application No. 03779297.5, mailed Mar. 15, 2007 (6 pages).
European Examination Report, European Application No. 04781644.2, mailed Aug. 23, 2007 (3 pages).
European Search Report, European Application No. 03729663.9, mailed Feb 20, 2008 (3 pages).
Falk, V., “Facilitated Endoscopic Beating Heart Coronary Artery Bypass Grafting Using a Magentic Coupling Device”, Journal of Thoracic and Cardiovascular Surgery, 126(5):1575-1579.
Filsoufi et al., “Automated Distal Coronary Bypass with a Novel Magnetic Coupler (MVP system)”, J. Thoracic and Cardiovascular Surgery, 127(1):185-192.
International Search Report and Written Opinion, International Patent Application No. PCT/US06/41255, mailed Jun. 13, 2008 (6 pgs.).
International Search Report and Written Opinion, International Patent Application No. PCT/US08/59429, mailed Sep. 5, 2008 (9 pgs.).
International Search Report for International Patent Application No. PCT/AU03/00759, filed Jun. 19, 2003.
International Search Report, International Application No. PCT/US02/40850 mailed Jun. 19, 2003 (4 pgs.).
International Search Report, International Application No. PCT/US03/01050, mailed Jul. 8, 2003 (1 pg.).
International Search Report, International Application No. PCT/US03/09051, mailed Sep. 29, 2003 (2 pgs.).
International Search Report, International Application No. PCT/US03/17390, mailed Oct. 6, 2003 (4 pgs.).
International Search Report, International Application No. PCT/US03/17715, mailed Mar. 24, 2004 (2 pgs.).
International Search Report, International Application No. PCT/US03/32133, mailed Apr. 22, 2004 (1 pg.).
International Search Report, International Application No. PCT/US03/34003 mailed Oct. 3, 2004 (4 pgs.).
International Search Report, International Application No. PCT/US03/35479, mailed Apr. 14, 2004 (2 pgs.).
International Search Report, International Application No. PCT/US03/35998 mailed Jun. 16, 2004 (5 pgs.).
International Search Report, International Application No. PCT/US03/39253, mailed Apr. 19, 2004 (4 pgs.).
International Search Report, International Application No. PCT/US04/022643, mailed Mar. 31, 2005 (2 pgs.).
International Search Report, International Application No. PCT/US04/026998, mailed Apr. 22, 2005 (5 pgs.).
International Search Report, International Application No. PCT/US04/029978, mailed Jan. 26, 2005 (3 pgs.).
International Search Report, International Application No. PCT/US05/006703, mailed Jul. 25, 2005 (3 pgs.).
International Search Report, International Application No. PCT/US05/013705 mailed Aug. 4, 2005 (4 pgs.).
International Search Report, International Application No. PCT/US05/015382, mailed Oct. 6, 2005 (4 pgs.).
International Search Report, International Application No. PCT/US05/34276, mailed Oct. 9, 2007.
International Search Report, International Application No. PCT/US06/009978, mailed Jul. 13, 2006 (2 pgs.).
International Search Report, International Application No. PCT/US07/065546, mailed Oct. 29, 2007 (4 pages).
International Search Report, International Application No. PCT/US2007/065526, mailed Aug. 8, 2007 (5 pgs.).
International Search Report, International Application No. PCT/US2007/065541, mailed Aug. 7, 2007 (4 pgs.).
International Search Report, International Application No. PCT/US97/14822, mailed Feb. 20, 1998 (2 pgs.).
International Search Report, International Application No. PCT/US97/17927, mailed Feb. 10, 1998 (1 pg.).
Kimura et al., “Effects of Neutron Irradiation on the Transformation Behavior in Ti-Ni Alloys”, Abstract, Proceedings of the Inn Conf. on Martensitic Transformations, 1992, pp. 935-940.
Klima, U., “Magnetic Vascular Port in Minimally Invasive Direct Coronary Artery Bypass Grafting”, Circulation, 2004, II-55-II-60.
Meier, MD, Bernhard, et al., “Contemporary Management of Patent Foramen Ovale,” American Heart Association, Inc., Circulation, 107:5-9 (2003).
Nat'l Aeronautics and Space Administration, “55-Nitinol—The Alloy with a Memory: Its Physical Metallurgy, Properties and Applications”, NASA Report, pp. 24-25.
Parviainen et al., “A New Biodegradable Stent for the Pancreaticojejunal Anastomosis After Pancreaticoduodenal Resection: In Vitro Examination and Pilot Experiences in Humans”, Pancreas, 21(1):14-21 (2000).
Ramanathan et. al., “Experimental and Computational Methods for Shape Memory Alloys,” 15th ASCE Engineering Mechanics Conference, Jun. 2-5, 2002.
Ruddy et al., “Rheological, Mechanical and Thermal Behaviour of Radipaque Filled Polymers”, Polymer Processing Research Centre, School of Chemical Engineering, Queen's University of Belfast, 5 pages.
Ruiz, et al., The Puncture Technique: A New Method for Transcatheter Closure of Patent Foramen Ovale, Catheterization and Cardiovascular Interventions, 53:369-372 (2001).
Shabalovskaya, S., “Surface, Corrosion amd Biocompatibility Aspects of Nitinol as and Implant Material”, Bio-Medical Materials and Engineering, 12:69-109 (2002).
SMST-2000, “Proceedings of the International Conference on Shape Memory and Superelastic Technologies”, Apr. 30 to May 4, 2000, Asilomar Conference Center.
Stockel, “Nitinol Medical Devices and Implants”, SMST-2000 Conference Proceedings, 2001, pp. 531-541.
Uchil, J., “Shape Memory Alloys—Characterization Techniques”, Pramana—Journal of Physics, 2002, vol. 58(5)(6), pp. 1131-1139.
Vaajanen et al., “Expansion and Fixation Properties of a New Braided Biodegradable Urethral Stent: An Experimental Study in the Rabbit”, The Journal of Urology, 169:1771-1174 (2003).
Related Publications (1)
Number Date Country
20130072965 A1 Mar 2013 US
Provisional Applications (1)
Number Date Country
60568527 May 2004 US
Continuations (1)
Number Date Country
Parent 11110975 Apr 2005 US
Child 13651643 US